(19)
(11) EP 1 304 921 A2

(12)

(88) Date of publication A3:
27.02.2003

(43) Date of publication:
02.05.2003 Bulletin 2003/18

(21) Application number: 01950688.0

(22) Date of filing: 29.06.2001
(51) International Patent Classification (IPC)7A01K 67/027, C07K 14/705, C07K 14/51, C07K 14/475, C12N 9/76, A61K 49/00, G01N 33/50
(86) International application number:
PCT/US0120/795
(87) International publication number:
WO 0200/1950 (10.01.2002 Gazette 2002/02)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 29.06.2000 US 215178 P
29.06.2000 US 215179 P
29.06.2000 US 215366 P
29.06.2000 US 215402 P
29.06.2000 US 215404 P
29.06.2000 US 215466 P
29.06.2000 US 215467 P
27.07.2000 US 221667 P
26.10.2000 US 244083 P

(71) Applicant: Deltagen, Inc.
Redwood City, CA 94063 (US)

(72) Inventors:
  • LEVITEN, Michael, W.
    Palo Alto, CA 94306 (US)
  • BRENNAN, Thomas, J.
    South San Francisco, CA 94080 (US)
  • GUENTHER, Catherine
    San Carlos, CA 94070 (US)
  • KLEIN, Robert
    Palo Alto, CA 94301 (US)
  • MATTHEWS, William
    Woodside, CA 94062 (US)
  • MOORE, Mark
    Redwood City, CA 94062 (US)

(74) Representative: Furlong, Isla Jane 
D. Young & Co.21 New Fetter Lane
London EC4A 1DA
London EC4A 1DA (GB)

   


(54) TRANSGENIC MICE CONTAINING TARGETED GENE DISRUPTIONS